{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:28:23Z","timestamp":1783355303592,"version":"3.54.6"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T00:00:00Z","timestamp":1378425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00702-013-1086-x","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T10:49:04Z","timestamp":1378378144000},"page":"1411-1419","source":"Crossref","is-referenced-by-count":27,"title":["Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10\/10-repeat allele which is more frequent in HIV-infected individuals"],"prefix":"10.1007","volume":"120","author":[{"name":"the German Competence Network HIV\/AIDS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Nolting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Joska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieghart","family":"Sopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Maschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Obermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo W.","family":"Husstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongai","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Koutsilieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/157015911795596612","volume":"9","author":"FR Buttarelli","year":"2011","unstructured":"Buttarelli FR, Fanciulli A, Pellicano C, Pontieri FE (2011) The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol 9:278\u2013288","journal-title":"Curr Neuropharmacol"},{"key":"1086_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307\u2013319","journal-title":"J Clin Exp Neuropsychol"},{"key":"1086_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30557","volume":"147B","author":"E Congdon","year":"2008","unstructured":"Congdon E, Lesch KP, Canli T (2008) Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet 147B:27\u201332","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1086_CR4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.mp.4001641","volume":"10","author":"KM Cornish","year":"2005","unstructured":"Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP (2005) Association of the dopamine transporter (DAT1) 10\/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10:686\u2013698","journal-title":"Mol Psychiatry"},{"key":"1086_CR5","first-page":"85","volume":"101","author":"S Czub","year":"2001","unstructured":"Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V (2001) Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol 101:85\u201391","journal-title":"Acta Neuropathol"},{"key":"1086_CR6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1310\/hct0806-437","volume":"8","author":"SR Evans","year":"2007","unstructured":"Evans SR, Yeh TM, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G (2007) Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clin Trials 8:437\u2013446","journal-title":"HIV Clin Trials"},{"key":"1086_CR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11481-006-9030-6","volume":"1","author":"BB Gelman","year":"2006","unstructured":"Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM (2006) Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 1:410\u2013420","journal-title":"J Neuroimmune Pharmacol"},{"key":"1086_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-6147(93)90029-J","volume":"14","author":"B Giros","year":"1993","unstructured":"Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43\u201349","journal-title":"Trends Pharmacol Sci"},{"key":"1086_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13365-011-0028-3","volume":"17","author":"S Gupta","year":"2011","unstructured":"Gupta S, Bousman CA, Chana G, Cherner M, Heaton RK, Deutsch R, Ellis RJ, Grant I, Everall IP (2011) Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings. J Neurovirol 17:239\u2013247","journal-title":"J Neurovirol"},{"key":"1086_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/498174","volume":"77","author":"Z Hawi","year":"2005","unstructured":"Hawi Z, Segurado R, Conroy J, Sheehan K, Lowe N, Kirley A, Shields D, Fitzgerald M, Gallagher L, Gill M (2005) Preferential transmission of paternal alleles at risk genes in attention-deficit\/hyperactivity disorder. Am J Hum Genet 77:958\u2013965","journal-title":"Am J Hum Genet"},{"key":"1086_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","volume":"22","author":"A Heinz","year":"2000","unstructured":"Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133\u2013139","journal-title":"Neuropsychopharmacology"},{"key":"1086_CR12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/jmv.21609","volume":"81","author":"GB Jacobs","year":"2009","unstructured":"Jacobs GB, Loxton AG, Laten A, Robson B, van Rensburg EJ, Engelbrecht S (2009) Emergence and diversity of different HIV-1 subtypes in South Africa, 2000\u20132001. J Med Virol 81:1852\u20131859","journal-title":"J Med Virol"},{"key":"1086_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(99)00101-8","volume":"46","author":"AM Kang","year":"1999","unstructured":"Kang AM, Palmatier MA, Kidd KK (1999) Global variation of a 40-bp VNTR in the 3\u2032-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46:151\u2013160","journal-title":"Biol Psychiatry"},{"key":"1086_CR14","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1097\/00001756-199712010-00034","volume":"8","author":"E Koutsilieri","year":"1997","unstructured":"Koutsilieri E, Gotz ME, Sopper S, Stahl-Hennig C, Czub M, ter Meulen V, Riederer P (1997) Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta). NeuroReport 8:3833\u20133836","journal-title":"NeuroReport"},{"key":"1086_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s007020200032","volume":"109","author":"E Koutsilieri","year":"2002","unstructured":"Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002) Involvement of dopamine in the progression of AIDS Dementia Complex. J Neural Transm 109:399\u2013410","journal-title":"J Neural Transm"},{"key":"1086_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","volume":"15","author":"AM Kumar","year":"2009","unstructured":"Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15:257\u2013274","journal-title":"J Neurovirol"},{"key":"1086_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bjp.0702389","volume":"126","author":"I Lamensdorf","year":"1999","unstructured":"Lamensdorf I, Porat S, Simantov R, Finberg JP (1999) Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo. Br J Pharmacol 126:997\u20131002","journal-title":"Br J Pharmacol"},{"key":"1086_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/13803395.2011.623118","volume":"34","author":"AJ Levine","year":"2012","unstructured":"Levine AJ, Sinsheimer JS, Bilder R, Shapshak P, Singer EJ (2012) Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV\u00a0+\u00a0adults. J Clin Exp Neuropsychol 34:78\u201391","journal-title":"J Clin Exp Neuropsychol"},{"key":"1086_CR19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1471-4159.2002.01212.x","volume":"83","author":"WF Maragos","year":"2002","unstructured":"Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83:955\u2013963","journal-title":"J Neurochem"},{"key":"1086_CR20","doi-asserted-by":"crossref","first-page":"e39135","DOI":"10.1371\/journal.pone.0039135","volume":"7","author":"R Mata","year":"2012","unstructured":"Mata R, Hau R, Papassotiropoulos A, Hertwig R (2012) DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART). PLoS One 7:e39135","journal-title":"PLoS One"},{"key":"1086_CR21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajmg.b.10948","volume":"114","author":"J Mill","year":"2002","unstructured":"Mill J, Asherson P, Browes C, D\u2019Souza U, Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3\u2032 UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114:975\u2013979","journal-title":"Am J Med Genet"},{"key":"1086_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/QCO.0b013e32834ef586","volume":"25","author":"NZ Mothobi","year":"2012","unstructured":"Mothobi NZ, Brew BJ (2012) Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 25:4\u20139","journal-title":"Curr Opin Infect Dis"},{"key":"1086_CR23","doi-asserted-by":"crossref","unstructured":"Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, Macrae E, Maljkovic-Berry I, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen MO, Schmit JC, Schuurman R, Soriano V, Stanczak J, Stanojevic M, Struck D, Van Laethem K, Violin M, Yerly S, Zazzi M, Boucher CA, Vandamme AM (2009) Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 6:49","DOI":"10.1186\/1742-4690-6-49"},{"key":"1086_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.22742","volume":"25","author":"FE Pontieri","year":"2010","unstructured":"Pontieri FE, Colosimo C (2010) Dopaminergic system in peripheral blood mononuclear cells in Parkinson\u2019s disease. Mov Disord 25:125\u2013126","journal-title":"Mov Disord"},{"key":"1086_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00042560-199503010-00008","volume":"8","author":"C Power","year":"1995","unstructured":"Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8:273\u2013278","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"1086_CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12035-011-8195-z","volume":"44","author":"V Purohit","year":"2011","unstructured":"Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders\/HIV-associated dementia. Mol Neurobiol 44:102\u2013110","journal-title":"Mol Neurobiol"},{"key":"1086_CR27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.1408","volume":"105","author":"T Roman","year":"2001","unstructured":"Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH (2001) Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105:471\u2013478","journal-title":"Am J Med Genet"},{"key":"1086_CR28","first-page":"1367","volume":"19","author":"NC Sacktor","year":"2005","unstructured":"Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19:1367\u20131374","journal-title":"AIDS"},{"key":"1086_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000049004","volume":"9","author":"B Saha","year":"2001","unstructured":"Saha B, Mondal AC, Majumder J, Basu S, Dasgupta PS (2001) Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4\u00a0+\u00a0and CD8\u00a0+\u00a0T cells in vitro: a receptor-mediated mechanism. NeuroImmunoModulation 9:23\u201333","journal-title":"NeuroImmunoModulation"},{"key":"1086_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e318278ffa4","volume":"62","author":"M Sakamoto","year":"2013","unstructured":"Sakamoto M, Marcotte TD, Umlauf A, Franklin D Jr, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson D, Grant I (2013) Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr 62:36\u201342","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1086_CR31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00001756-199603220-00015","volume":"7","author":"AM Sardar","year":"1996","unstructured":"Sardar AM, Czudek C, Reynolds GP (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. NeuroReport 7:910\u2013912","journal-title":"NeuroReport"},{"key":"1086_CR32","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s007020070012","volume":"107","author":"C Scheller","year":"2000","unstructured":"Scheller C, Sopper S, Jassoy C, ter Meulen V, Riederer P, Koutsilieri E (2000) Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 107:1483\u20131489","journal-title":"J Neural Transm"},{"key":"1086_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1471-4159.2005.03373.x","volume":"95","author":"C Scheller","year":"2005","unstructured":"Scheller C, Sopper S, Jenuwein M, Neuen-Jacob E, Tatschner T, Grunblatt E, ter Meulen V, Riederer P, Koutsilieri E (2005) Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem 95:377\u2013387","journal-title":"J Neurochem"},{"key":"1086_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00702-010-0415-6","volume":"117","author":"C Scheller","year":"2010","unstructured":"Scheller C, Arendt G, Nolting T, Antke C, Sopper S, Maschke M, Obermann M, Angerer A, Husstedt IW, Meisner F, Neuen-Jacob E, Muller HW, Carey P, Ter Meulen V, Riederer P, Koutsilieri E (2010) Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses. J Neural Transm 117:699\u2013705","journal-title":"J Neural Transm"},{"key":"1086_CR35","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","volume":"69","author":"G Schifitto","year":"2007","unstructured":"Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB (2007) A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 69:1314\u20131321","journal-title":"Neurology"},{"issue":"Suppl 7","key":"1086_CR36","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/mds.10578","volume":"18","author":"GR Uhl","year":"2003","unstructured":"Uhl GR (2003) Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord 18(Suppl 7):S71\u2013S80","journal-title":"Mov Disord"},{"key":"1086_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2967\/jnumed.108.053652","volume":"50","author":"E Giessen van de","year":"2009","unstructured":"van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J (2009) Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50:45\u201352","journal-title":"J Nucl Med"},{"key":"1086_CR38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0888-7543(05)80138-7","volume":"14","author":"DJ Vandenbergh","year":"1992","unstructured":"Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104\u20131106","journal-title":"Genomics"},{"key":"1086_CR39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3171\/jns.2007.106.4.538","volume":"106","author":"AK Wagner","year":"2007","unstructured":"Wagner AK, Ren D, Conley YP, Ma X, Kerr ME, Zafonte RD, Puccio AM, Marion DW, Dixon CE (2007) Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg 106:538\u2013547","journal-title":"J Neurosurg"},{"key":"1086_CR40","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/brain\/awh269","volume":"127","author":"GJ Wang","year":"2004","unstructured":"Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452\u20132458","journal-title":"Brain"},{"key":"1086_CR41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-4159.1990.tb01942.x","volume":"54","author":"P Wester","year":"1990","unstructured":"Wester P, Bergstrom U, Eriksson A, Gezelius C, Hardy J, Winblad B (1990) Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 54:1148\u20131156","journal-title":"J Neurochem"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1086-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:52:01Z","timestamp":1553626321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1086-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}